McNeil Consumer
This article was originally published in The Tan Sheet
Executive Summary
J&J unit will market Pharmacia's nicotine nasal spray in North America under an agreement with the Swedish pharmaceutical company. McNeil already markets the Nicotrol nicotine patch, which is manufactured by Cygnus under license from Pharmacia. In August, FDA's Drug Abuse Advisory Committee recommended that the nasal spray for smoking cessation be treated as a Drug Enforcement Agency Schedule V controlled substance, the least restrictive of DEA classifications ("The Tan Sheet" Aug. 8, p. 10)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning